CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 419,927 enrolled
Drug / intervention
Apple Heart Study Appdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03335800
NCT03335800N/ACompleted

Apple Heart Study: Assessment of Wristwatch-Based Photoplethysmography to Identify Cardiac Arrhythmias

Apple Inc.·interventional·Posted Nov 8, 2017·Updated Mar 30, 2020

In Brief

A clinical study evaluating Apple Heart Study App for Atrial Fibrillation and 2 related conditions. Completed, enrolled 419,927 participants across 1 site.

Detailed Summary

The Apple Heart Study (AHS) is a research study conducted to evaluate whether the Apple Heart Study App can use data collected on the Apple Watch to identify irregular heart rhythms, including those from potentially serious heart conditions such as atrial fibrillation. Up to 500,000 can participate in the study.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsStanford University

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedNov 8, 2017
Enrollment StartNov 29, 2017
Primary CompletionFeb 21, 2019
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 8.7 years ago

Interventions

Apple Heart Study Appdevice

The Apple Heart Study app is a mobile medical app that analyzes pulse rate data. The app identifies episodes of irregular heart rhythms consistent with atrial fibrillation and other arrhythmias.